Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
Deontics
Clinical pathway decision support
Health data & AI platformsClinical workflow & hospital operations
London clinical decision support company whose rules-based AI encodes cancer treatment pathways to help multidisciplinary teams triage patients to the right care faster.
The read
Deontics builds rules-based clinical decision support software that encodes agreed cancer treatment pathways, helping multidisciplinary teams triage patients to standard of care faster. Its prostate cancer pathway tool, evaluated at Guy's and St Thomas' and King's College Hospital, was reported to triage a third of patients straight to standard of care without needing a full MDT discussion.
The underlying technology traces back to research at the UK Medical Research Council, Cancer Research UK, Oxford University and UCL, led by the late Professor John Fox, a pioneer of the clinical-logic language underpinning the platform.
The Bridgehead view
Deontics' peer-reviewed evaluation in a clinical journal, rather than a company blog post, is a rarer standard of evidence in this cohort and worth highlighting whenever the story is about AI's readiness for genuine clinical triage decisions rather than administrative support.
FAQs
About this page
No. The MedTech Index is independent editorial coverage — we track and write up companies we judge genuinely significant in the sector, and inclusion is not for sale. Where shown, coverage of Deontics above is drawn from public reporting, not sponsored content.
We map the sector by who is actually shaping it: funding, product reach, regulatory engagement and the coverage they earn. The MedTech Index is maintained by our editorial team and updated as the market moves, not compiled from vendor submissions.
Yes. If you represent Deontics, or anything here looks out of date, get in touch through our contact page and we will review it.
Work with us
Working across the healthcare sector?
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
Related platforms
Others in the sector map
Rare disease diagnosis AI
Mendelian
AI clinical decision support that scans GP electronic health records to flag patients who may have one of thousands of rare diseases, years earlier than standard care typically catches them.
ReadCancer treatment-response prediction
Concr
London/Cambridge techbio company applying astrophysics-derived modelling, its FarrSight platform, to predict how cancer patients will respond to treatment and simulate clinical trials.
ReadEarly cancer detection decision-support for primary care
C the Signs
London platform using validated clinical datapoints to flag likely cancer cases in primary care within around 60 seconds, founded by a practising GP.
ReadApplied AI and decision intelligence (acquired)
Faculty
UK applied-AI company that built NHS COVID-19 forecasting tools and decision-intelligence software, acquired by Accenture in 2026 in the largest-ever purchase of a private UK AI startup.
ReadHealth information exchange
Graphnet Health
Interoperability vendor whose Care Information Exchange and CareCentric platforms create shared care records across NHS Integrated Care Systems, operating alongside System C Healthcare under the same private-equity owner.
ReadNHS interoperability consultancy
Aire Logic
Employee-owned technology consultancy building the FHIR and NHS Spine interoperability infrastructure behind several of the NHS's largest recent digital contracts.
ReadThe firm that knows medtech
We map this sector because
we represent it.
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.
